<DOC>
	<DOCNO>NCT02005328</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy , safety acceptability three new oral spray reference oral spray relief drug-induced xerostomia associate hyposialia , i.e . dryness mouth induce decrease salivation ( hyposialia ) induce chronic drug intake .</brief_summary>
	<brief_title>Exploratory Study Relief Drug-induced Xerostomia Associated With Hyposialia</brief_title>
	<detailed_description />
	<mesh_term>Xerostomia</mesh_term>
	<criteria>Male female subject , Adult subject ( ≥18 year ) take drug ( ) cause salivary hypofunction / xerostomia , least 1 week prior study initiation expect continue without change study Subjects complaint dry mouth assess response 40mm great item `` Rate dryness mouth '' Dry Mouth Visual Analogue Scale ( VAS ) question . ( The VAS limit 0 represent normal [ i.e . dry mouth symptom ] 100 represent `` bad imaginable '' dry mouth symptom ) . This score also meet 1st product application , P1 D1 . Documented hyposalivation test rest saliva weight absorb ≤ 0.5g/5 min baseline Presence disorder ( buccodental disease , history major medical/psychiatric illness surgery , ... ) , judgement investigator , may interfere study implementation and/or study parameter assessment ( ) . Sjögren syndrome relate autoimmune disease , Other medical cause xerostomia ( oral candidiasis ) . History head neck irradiation cancer chemotherapy History hypersensitivity component investigational product , History current excessive use alcohol , History drug addiction , Presence treatment dry mouth within 7 day prior inclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Xerostomia</keyword>
	<keyword>hyposialia</keyword>
	<keyword>hyposalivation</keyword>
	<keyword>saliva substitute</keyword>
	<keyword>Salivary Gland</keyword>
	<keyword>Mouth Diseases</keyword>
	<keyword>Dry mouth</keyword>
</DOC>